NanoEcho advanced clinical preparations and completed a successful share issue in Q3 2024, maintaining a strong equity position while progressing toward commercialization of its rectal cancer diagnostic system.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.